CERUS CORP(CERS)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

CERUS CORP (CERS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CERS at 38.5/100 on a 32-signal composite quality model, placing it at rank #2,188 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (18.0) and revenue scale (24.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 16.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), CERUS CORP reports quarterly revenue of $57.4M, net income of $-2.9M, an operating margin of -3.2%. Top institutional holders of CERS by reported 13-F value include BlackRock, ARK Investment Management, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. CERS trades on the Nasdaq exchange and files with the SEC under CIK 1020214. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CERS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CERUS CORP directly from SEC EDGAR.